Coronavirus: Emergency planning for the drug supply chain
The FDA has outlined its expectations and actions regarding supply chain and inspections in China
Breaking News
DuPont enters microbiome therapy collaboration with MRM Health
MRM has raised more than $15m to advance its clinical and preclinical development programmes
The Native Antigen Company introduces novel coronavirus antigen
UK company has developed rapid response manufacturing capabilities to produce reagents for emerging epidemic diseases
CNS Pharmaceuticals completes FDA reprocessing stipulations for API
US-based biotech has completed pilot manufacturing steps persuant to FDA pre-IND guidance for production of API for new ...
The Lonza powder-in-capsule microdosing approach
Jeff Williamson and Ben Sahacic explain how microdosing offers a proven approach for biopharmaceutical companies to ...
Uni teams develop new hydrogel-based fermentation production method
Texas and Washington University teams have developed a new way to produce molecules on demand and preserve them using ...
Novo Nordisk plans $117m API manufacturing expansion
Danish company’s Kalundborg headquarters that manufactures insulin API will be expanded by 2022
John Baker: Life sciences need to address the reproducibility crisis
The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...
Indena receives Gates Foundation grant to optimise antimalarials
The Gates Foundation has funded a strategic project to improve two new potential antimalarial synthetic drug therapies ...
GE Healthcare collaborates to develop ligands for AAV purification
Australian Children’s Medical Research Institute and GE have agreed to develop new affinity ligands for the ...
UK medical cannabis: Quality under scrutiny
Andrew James, Marketing Director of Ellutia, explains how chromatography can uncover the potency of a batch of cannabis ...
IntelGenx: Oral films are drug development’s patent trick
Exploiting improvements in bioavailability, the Canadian company has developed unique oral film technology to help ...
Managing the unavoidable: A practical approach to handling TUPs
Technically unavoidable particles (TUPs) are found in chemical raw materials, such as excipients. They do not pose a ...
Avacta, Daewoong and AffyXell to work on proteins for a range of targets
AffyCell has agreed to provide funds to Avacta for R&D costs of proteins produced by mesenchymal stem cells
CPI evaluates NADH recycling tech from Oxford University
The Centre for Process Innovation has worked with Oxford Uni to scale up beads with immobilised enzymes that recycle ...
In Brief
Most Popular in Ingredients
Featured Companies
Reports
